title: Soluble IL-2 receptor beta and gamma subunits: ligand binding and cooperativity.
abstract: Biologically relevant interleukin-2 receptors (IL-2Rs) are present in two affinity states on responsive cells. High affinity receptors (HAR) apparently exist as heterotrimers (alpha, beta and gamma) while the other functional complex, the intermediate affinity receptor (IAR), is comprised of beta and gamma chains. The mechanisms by which the beta and gamma subunits contribute the formation of HAR and IAR are still unclear. Soluble forms of the beta and gamma chains were cloned, epitope-tagged, expressed in insect cells and purified. IL-2 binding and neutralization of IL-2 bioactivity by beta and gamma extracellular domains (ectodomains) was analyzed by several biochemical and biological approaches. The results indicate that beta clearly binds IL-2 with low affinity (KI-KD = 3 microM) whereas gamma binding is detectable, but of very low affinity (apparent KI > 15 microM) in the absence of beta. Interestingly, combinations of beta and gamma ectodomains interact to bind IL-2 with higher affinity and greater stability than either chain alone. An apparent stable binding complex is formed when beta, gamma, and IL-2 are combined. Ligand binding by the beta and gamma chains in solution is specific for IL-2 and is of sufficient affinity and stability to effectively neutralize IL-2 in biological assays (binding IC50 = biological IC50). Direct analyses of binding kinetics by surface plasmon resonance reveals that the increased affinity and biological neutralizing ability of beta gamma, as compared to beta, is due to a very slow dissociation rate contributed by the gamma ectodomain. While IL-2R beta and gamma cytoplasmic and transmembrane domains are not essential for interactive binding of IL-2, they may contribute to IL2 binding affinity. The recognition and association of IL-2 by the beta gamma IAR appears to be contributed primarily by the beta chain while the stability and dissociation is likely dominated by the gamma chain. It is anticipated that the gamma subunit functions in a similar manner when participating in high affinity IL-4 and IL-7 binding.
authors.affiliation: Dept. of Cell Biology, Chiron Corporation, Emeryville, CA 94608.
authors.forename: K
authors.initials: K
authors.lastname: Johnson
authors.forename: Y
authors.initials: Y
authors.lastname: Choi
authors.forename: Z
authors.initials: Z
authors.lastname: Wu
authors.forename: T
authors.initials: T
authors.lastname: Ciardelli
authors.forename: R
authors.initials: R
authors.lastname: Granzow
authors.forename: C
authors.initials: C
authors.lastname: Whalen
authors.forename: T
authors.initials: T
authors.lastname: Sana
authors.forename: G
authors.initials: G
authors.lastname: Pardee
authors.forename: K
authors.initials: K
authors.lastname: Smith
authors.forename: A
authors.initials: A
authors.lastname: Creasey
mesh_terms: D001667:Binding, Competitive; D018076:DNA, Complementary / Q000235:genetics; D006801:Humans; D007376:Interleukin-2 / Q000378:metabolism*; D007700:Kinetics; D008024:Ligands; D010446:Peptide Fragments / Q000378:metabolism; D011485:Protein Binding; D011487:Protein Conformation; D015375:Receptors, Interleukin-2 / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000302:isolation & purification / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: D018076:DNA, Complementary; D007376:Interleukin-2; D008024:Ligands; D010446:Peptide Fragments; D015375:Receptors, Interleukin-2; D011993:Recombinant Fusion Proteins